 | SNGX: Innate Defense Regulators Offer New Approach to Treating Infections
finance.yahoo.com - February 12 at 7:22 PM |
| Soligenix Receives US Patent Expanding Protection for its Ricin Toxin Vaccine, RiVax®
finance.yahoo.com - February 11 at 8:26 AM |
 | Soligenix, Inc. (SNGX) Given $6.25 Average Target Price by Analysts
www.americanbankingnews.com - February 8 at 10:07 AM |
| Soligenix Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate
finance.yahoo.com - February 7 at 8:16 AM |
 | Soligenix nabs new patent in Europe
seekingalpha.com - January 23 at 8:11 AM |
 | Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs
www.prnewswire.com - January 23 at 6:37 AM |
| Soligenix to raise $611K via sale of NJ tax credits
seekingalpha.com - December 11 at 8:31 AM |
| Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
finance.yahoo.com - December 11 at 8:31 AM |
| Soligenix Announces Publication of Scientific Review Discussing Clinical Applications of Innate Defense Regulator Technology
finance.yahoo.com - December 5 at 8:13 AM |
| Soligenix Selected to Present RiVax® Data at the Fourth International Conference on Vaccines Research & Development in Baltimore, Maryland
finance.yahoo.com - November 12 at 8:18 AM |
| Soligenix EPS in-line, beats on revenue
seekingalpha.com - November 9 at 8:17 AM |
| SNGX: Transferring Coverage; Positive Feedback from Interim Analysis gives SGX301 Phase 3 Trial 90% probability of success…
finance.yahoo.com - October 16 at 5:01 PM |
| SNGX: Q&A with Soligenix Chief Medical Officer Dr. Richard Straube Regarding the Interim Analysis for the Phase 3 Trial of SGX301
finance.yahoo.com - October 15 at 5:09 PM |
| Soligenix to increase enrollment in late-stage study of SGX301 in CTCL
seekingalpha.com - October 15 at 8:16 AM |
| Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
finance.yahoo.com - October 15 at 8:16 AM |
| Soligenix Announces Poster Presentations of its Ricin Vaccine and Dusquetide Oral Mucositis Programs at the 2018 NORD Rare Diseases and Orphan Products Breakthrough Summit
finance.yahoo.com - October 4 at 8:12 AM |
| SNGX: What Can We Expect from the Upcoming Interim Analysis of Phase III SGX301 for CTCL?
finance.yahoo.com - September 14 at 5:03 PM |
| NIH selects Soligenix's SGX942 in the Treatment of Oral Mucositis for the Commercialization Accelerator Program
finance.yahoo.com - September 13 at 8:20 AM |
| Soligenix to Present at BioCentury's 25th Annual NewsMakers in the Biotech Industry
finance.yahoo.com - September 5 at 8:18 AM |
| Soligenix Announces Publication of Positive Long-Term Data Supporting Thermostability and Conformational Integrity of the RiVax® Ricin Toxin Vaccine
finance.yahoo.com - September 4 at 8:21 AM |
| Soligenix to Present at the 2018 ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
finance.yahoo.com - August 29 at 8:23 AM |
| Soligenix Receives US Patent for Improved Production of Synthetic Hypericin
finance.yahoo.com - August 22 at 8:18 AM |
| SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Soligenix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - August 13 at 8:10 AM |
| Soligenix Announces Recent Accomplishments And Second Quarter 2018 Financial Results
finance.yahoo.com - August 8 at 8:19 AM |
| Soligenix Announces a RiVax® Program Presentation at the 31st Annual Congress on Vaccines, Clinical Trials & B2B in Vancouver, Canada
finance.yahoo.com - July 26 at 8:14 AM |
| Soligenix Receives European and Canadian Patents for its Ricin Toxin Vaccine (RiVax®) Formulation
finance.yahoo.com - July 9 at 8:12 AM |
| SNGX: New Financing Boosts Balance Sheet
finance.yahoo.com - July 6 at 4:48 PM |
| Soligenix, Inc. Prices $8,000,000 Public Offering At The Market
finance.yahoo.com - June 28 at 8:34 AM |
| Soligenix Announces Poster at the 2018 American Society of Microbiology Microbe Conference in Atlanta, Georgia
finance.yahoo.com - June 12 at 8:15 AM |
| Soligenix Inc’s (NASDAQ:SNGX) Shift From Loss To Profit
finance.yahoo.com - May 25 at 5:57 PM |
| SNGX: ThermoVax Technology May be the Solution of Developing Heat Stable Ebola Vaccine
finance.yahoo.com - May 23 at 5:40 PM |
| Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results
finance.yahoo.com - May 11 at 8:18 AM |
| Soligenix to Present at the NYC Oncology Investor Conference 2018
finance.yahoo.com - May 7 at 8:15 AM |
 | Soligenix, Inc. (SNGX) Granted Orphan Drug Designation from European Commission for RiVax for Prevention of Ricin Poisoning
www.streetinsider.com - March 23 at 8:15 AM |
 | 28 Stocks Moving In Thursday's Mid-Day Session
feeds.benzinga.com - March 22 at 2:31 PM |
| Soligenix Receives Orphan Drug Designation from the European Commission for RiVax® for Prevention of Ricin Poisoning
finance.yahoo.com - March 22 at 8:21 AM |
| Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
finance.yahoo.com - March 15 at 8:12 AM |
| Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
www.prnewswire.com - January 25 at 8:02 AM |
| Blog Exposure - Soligenix Announced Issuance of US Patent for Use of Dusquetide in Oral Mucositis
finance.yahoo.com - January 4 at 11:01 AM |
| Soligenix (SNGX): Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule
finance.yahoo.com - December 21 at 3:46 PM |
| Soligenix Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule
www.prnewswire.com - December 21 at 6:26 AM |
| Want To Invest In Soligenix Inc (SNGX)? Here’s How It Performed Lately
finance.yahoo.com - December 8 at 3:50 PM |
| Soligenix Announces Presentation and Poster at the 2017 Chemical and Biological Defense Science and Technology Conference in Long Beach, CA
finance.yahoo.com - November 27 at 4:13 PM |
| Who Owns Most Of Soligenix Inc (SNGX)?
finance.yahoo.com - November 15 at 10:06 AM |
| Soligenix Announces Closing of $5,115,000 Concurrent Registered Direct Offering and Private Placement of Common Stock Priced Above Market
finance.yahoo.com - November 4 at 4:05 PM |
| Soligenix Announces $700,000 Subaward Supporting Development Collaboration on Thermostabilization of an Ebola Vaccine Candidate
finance.yahoo.com - September 27 at 8:44 AM |
| Soligenix, Inc. :SNGX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 20, 2017
finance.yahoo.com - September 23 at 7:31 AM |
| Soligenix (SNGX): Two SBIR Grant Awarded Supporting Two Pivotal Phase III Trials
finance.yahoo.com - September 23 at 7:31 AM |
| Soligenix, Inc. (Nasdaq: SNGX) to Ring The Nasdaq Stock Market Closing Bell
feeds.benzinga.com - August 30 at 11:13 AM |
| Soligenix Begins Patient Enrollment for Pivotal Phase 3 Trial (SGX942) for Oral Mucositis & Enrollment in Phase III of SGX301 ongoing
finance.yahoo.com - August 2 at 4:38 PM |
